Minerva ginecologica 1991-01-01

[Vulvar lesions caused by Papillomavirus (HPV): effectiveness of thymopentin (Syntomoduline). First results and experiences].

L Di Stefano, D Facchini, A L De Paulis, F Cappa, M Moscarini

Index: Minerva Ginecol. 43(1-2) , 53-6, (1991)

Full Text: HTML

Abstract

The study included two different sized groups of patients suffering from various degrees of valvular microcondylomatosis. A group of 40 patients was treated using combined therapy while a second group of 20 patients received immunomodulating therapy alone with Sintomodulin. In particular, possible changes in the T-cell line of the immune system and correlations between the viral lesion and variations in serum levels of lymphocyte subpopulations were assessed. Results were analysed up to one year after the end of therapy.

Related Compounds

  • Thymopentin

Related Articles:

Stability and aerosolization of pressurized metered dose inhalers containing thymopentin nanoparticles produced using a bottom-up process.

2012-05-10

[Int. J. Pharm. 427(2) , 385-92, (2012)]

Separation and purification of thymopentin with molecular imprinting membrane by solid phase extraction disks.

2015-01-01

[J. Pharm. Biomed. Anal. 102 , 137-43, (2014)]

Peptides and polypeptides as modulators of the immune response: thymopentin--an example with unknown mode of action.

1999-06-01

[Pharm. Acta Helv. 73(6) , 265-73, (1999)]

Immunomodulation with thymopentin: in vitro studies.

1989-01-01

[Med. Oncol. Tumor Pharmacother. 6(1) , 19-23, (1989)]

Thymopoietin to thymopentin: experimental studies.

1985-01-01

[Surv. Immunol. Res. 4 Suppl 1 , 1-10, (1985)]

More Articles...